Teriparatide Sun Unión Europea - español - EMA (European Medicines Agency)

teriparatide sun

sun pharmaceutical industries europe b.v. - teriparatida - osteoporosis; osteoporosis, postmenopausal - homeostasis del calcio - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

DUPIXENT® Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

dupixent®

sanofi - aventis groupe francia - dupilumab 300 mg - solucion inyectable - cada jeringuilla precargada contiene (a): dupilumab 300 mg

DUPIXENT® 200 mg / 1.14 mL Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

dupixent® 200 mg / 1.14 ml

sanofi - aventis groupe francia - dupilumab 200 mg - soluciÓn inyectable - cada jeringuilla precargada contiene (a): dupilumab 200 mg